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Abstract
Background Insomnia is common leading to patients with sleep
problems often presenting to primary care services including gen-
eral practice, community pharmacies and community mental
health teams. Little is known about how health professionals in
primary care respond to patients with insomnia.
Aim We aimed to explore health professionals’ and patients’
experiences and perceptions of the management of insomnia in
primary care.
Design We used a qualitative design and thematic approach.
Setting Primary care in Nottinghamshire and Lincolnshire.
Method We undertook focus groups and one-to-one interviews with
a purposive sample of health professionals and adults with insomnia.
Results We interviewed 28 patients and 23 health professionals.
Practitioners focused on treating the cause of insomnia rather than
the insomnia itself. They described providing stepped care for
insomnia, but this focused on sleep hygiene which patients often
disregarded, rather than cognitive behavioural therapy for insom-
nia (CBT-I). Practitioners were ambivalent towards hypnotic drugs
but often colluded with patients to prescribe to avoid confronta-
tion or express empathy. Patients sometimes took hypnotics in
ways that were not intended, for example together with over-
the-counter medication. Practitioners and patients were sometimes
but not always concerned about addiction. Practitioners sometimes
prescribed despite these concerns but at other times withdrew
hypnotics abruptly without treating insomnia. Both patients and
practitioners wanted more options and better training for the man-
agement of insomnia in primary care.
Conclusion A better understanding of the current approaches and
difficulties in the management of insomnia will help to inform
more therapeutic options and health professional training.
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Introduction
Insomnia affects up to 30 percent of the adult
population in the UK and the United States in
any one year.1,2 It is associated with increased
health-care utilization3 and costs.4 Poor sleepers
are as follows: more likely to have had a con-
sultation with a health-care professional in the
past year5; slower to recover from acute ill-
nesses; more often hospitalized6; and at risk of
increased overall mortality.7
National guidance for insomnia management
recommends sleep hygiene advice, access to
non-pharmacological treatments, such as cogni-
tive behavioural therapy for insomnia (CBT-I)
and finally short-term prescribing of hypnotic
drugs in cases of severe insomnia that interferes
with daily life.8 Hypnotics are only licensed on
a short-term basis because of tolerance, depen-
dency and withdrawal effects.8 Nonetheless,
there is also evidence to suggest that longer-
term hypnotic prescribing occurs on a regular
basis.9
Previous research has shown that prescribers
are generally cautious about initiating ben-
zodiazepines, most of which are now prescribed
as hypnotics.10 Most practitioners are aware
that hypnotics should be used only in the
short-term and for acute situations, such as
bereavement.11 Despite this, long-term pre-
scribing is common,9 because of prescribers’
(usually doctors’) hesitance to disrupt patients’
established sleep patterns; patient reluctance to
discontinue therapy and dependence on hypn-
otics.12 Other factors influencing longer-term
prescribing include the following: prescribing
previously established by another doctor; prac-
titioners’ high workload; and time constraints
dealing with patients who have insomnia com-
orbidity with multiple long-term conditions
and complex psychosocial problems.11,13
The aim of this research was to understand
the current experiences and views of patients
and the wider primary care health team,
including general practitioners (GPs), pharma-
cists and community mental health teams
(CMHT) on the treatment for insomnia.
The research questions were as follows:
1. What treatment strategies did primary care
practitioners use for patients with insomnia?
2. What were patients’ views about primary
care treatments for insomnia?




We used a qualitative design and a thematic
approach. We conducted focus groups (FGs)
and one-to-one interviews lasting between 40
and 60 min with people who had suffered with
insomnia and health professionals involved in
treating insomnia, to understand the range of
experiences, actions and intentions and the
meanings associated with them. We chose to
incorporate both individual interviews and
FGs to gather individual and collective
responses because these give rise to different
forms of data. FGs tend to offer consensus
alongside contentious views, while individual
interviews tend to offer more introspective
data. The responses generated in FGs allow
participants to explore and clarify views in
ways that would be less easily accessible in a
one-to-one interview; they also have the poten-
tial to trigger ideas, which help participants to
think, clarify thoughts and then respond.14
Participants
We interviewed 28 patients (for ease of termi-
nology, both patients and service users are
referred to as patients in this paper) and 23
health professionals between January and July
2011; these included 17 individual and three
randomly allocated FG interviews with
patients. We offered patients the chance to be
interviewed alone or as part of a FG. There
were two single sex (female) FGs (n = 3 9 2)
and a mixed sex FG (n = 5). Eight individual
interviews and three profession-based FGs with
a total of nine GPs, two primary care nurses,
five pharmacists and seven mental health
professionals were conducted. Participants were
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recruited from Lincolnshire and Nottingham-
shire, UK. Patients were recruited through
posters in public places and family practice
waiting rooms. Health professionals were
recruited from direct mailing to practitioners
or via clinical leads. We stopped recruiting
patients and professionals to the study when
lines of enquiry in relation to the research
questions were exhausted (Tables 1 and 2).
Interview schedule
Separate semi-structured topic guides were
used for patients and practitioners to elicit
participants’ beliefs about current treatments
for insomnia, although these were similar for
FGs or face-to-face interviews. We asked
patients about their sleep problems, what they
had tried to resolve them and where they had
found useful advice (if indeed they had). For
professionals, we explored their current treat-
ment practices for a patient presenting with
insomnia and what their perceptions of
patients’ expectations were.
Analysis
All interviews were transcribed verbatim. Inter-
view data were managed using NVivo 8 (QSR
International Pty Ltd, Doncaster, Victoria,
Australia). We used thematic analysis; analy-
sing data concurrently with collection allowed
us to explore new avenues of enquiry during
the fieldwork. This process included the follow-
ing: familiarization with the data; generating
initial descriptive codes; and searching for
Table 1 Participants: health professionals
Study ID Gender Profession Length of time practicing
General practitioners
GP Prof. Int. 031 Man GP 10 years
GP Prof. Int. 04 Man Salaried GP 2 ½ years
GP Prof. FG. 172 Man GP Principal 23 years doctor, 5 years GP
GP Prof. FG. 22 Man GP Principal 34 years
GP Prof. FG. 23 Woman GP Principal 5 years
GP Prof. FG. 24 Woman GP Principal <1 year
GP Prof. FG. 25 Woman GP Trainee 3rd year 5 years
GP Prof. FG. 26 Man GP Principal 18 years
GP Prof. FG. 27 Woman SPST On-going
Nurses
N Prof. Int. 18 Woman Nurse Practitioner 5 years
N Prof. Int. 21 Woman Practice Nurse (PN) 17 years nurse, 7 years PN
Community pharmacists
CP Prof. Int. 12 Man 20 years
CP Prof. FG. 13 Woman 31 years
CP Prof. FG. 14 Man 24 years
CP Prof. FG. 19 Woman 9 years
CP Prof. FG. 20 Woman 35 years
Community Mental Health Team (CMHT)
CMHT Prof. Int. 02 Woman Doctor Adolescents/children 15 years
CMHT Prof. Int. 073 Woman 20 years
CMHT Prof. Int. 08 Man 2 years
CMHT Prof. Int. 09 Woman 15 years
CMHT Prof. FG. 01 Woman 2 ½ years
CMHT Prof. FG. 10 Woman 2 years
CMHT Prof. FG. 11 woman 3 years
1Int, individual interview.
2FG, focus group.
3Community mental health team were either CBT therapists or psychological wellbeing practitioners.
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underlying themes, reflecting on deeper notions
and conceptualizations.15,16 Codes were both
theory- (deductive) and data-driven (inductive).
The process involved each of the authors devel-
oping initial codes, two of the authors contin-
uing to code data to generate new codes and
potential themes. All three authors then
reviewed the codes and themes together itera-
tively to generate the final themes and choose
the quotations, which best illustrated these.
Ethical approval
Leicestershire, Northamptonshire & Rutland
Research Ethics Committee Reference 10/
H0406/78. Research Governance approvals
were sought and gained from both Notting-
hamshire and Lincolnshire Primary Care Trust
and Mental Health Trusts.
Results
Four main themes emerged (Box 1):
Box 1 Themes
Responses to insomnia
Prescribing and drug taking
Addiction and withdrawal
More options, better education and training
Responses to insomnia
General practitioners and patients often
described a stepped-care approach to treating
insomnia, starting with a psychosocial assess-
ment, followed by advice on sleep hygiene
which often consisted of a single sheet of
Table 2 Participants: patients
Study ID Gender Age Perceived/diagnosed cause of insomnia
Pt. Int. 011 Woman 62 Mental health condition, physical condition (pain)
Pt. FG. 02 Woman 45 Mental health condition
Pt. Int. 03 Woman 53 Physical condition (pain)
Pt. Int. 04 Woman 60 Mental health condition, physical condition
Pt. Int. 05 Woman 70 Caring responsibilities, mental health condition, physical conditions including pain
Pt. FG. 09 Woman 52 Mental health condition
Pt. Int. 10 Woman 66 Undisclosed
Pt. Int. 11 Man 36 Insomnia, caring responsibilities, bereavement
Pt. Int. 12 Woman 32 Bereavement
Pt. Int. 15 Man 20 Bereavement
Pt. FG. 18 Man 50 Mental health condition environmental issues
Pt. FG. 19 Woman 69 Mental health condition
Pt. FG. 20 Woman 45 Physical condition (pain)
Pt. Int. 21 Woman 56 Undisclosed
Pt. FG. 22 Woman 43 Mental health issues, relationship issues
Pt. Int. 23 Man 23 Bereavement
Pt. Int. 26 Man 35 Physical condition, mental health condition, relationship issues
Pt. Int. 27 Man 55 Physical condition, mental health condition, caring responsibilities
Pt. Int. 28 Woman 64 Physical conditions
Pt. FG. 29 Woman 23 Undisclosed
Pt. FG. 30 Woman 51 Physical conditions
Pt. Int. 31 Man 38 Mental health conditions
Pt. FG. 33 Woman 22 Mental health condition, Socio-environment issues
Pt. FG. 34 Man 28 Caring responsibilities, mental health condition, socio-environmental issues
Pt. FG. 35 Man 54 Undisclosed
Pt. Int. 36 Man 51 Physical conditions
Pt. Int. 39 Man 36 Mental health condition, social issues
Pt. Int. 40 Man 57 Stress-related issues
1Pt, patient.
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information printed out at the consultation.
Following this, medication was considered. The
psychosocial assessment consisted of: a mental
health review for depression or anxiety and
screening for physical (e.g. pain, sleep apnoea),
occupational (variable shift patterns) and social
(relationship or financial difficulties) causes.
GPs often focused on treating causes before
insomnia itself, and their perception of causa-
tion was often influenced by consideration of
patients’ socio-economic status, particularly in
areas of high social deprivation.
We try to explore the reasons why they are not
sleeping, so after finding out those reasons, treat-
ment depends on what the causes are. Most of
them are [due to] social [problems]. (GP Prof.
Int. 04)
According to most of the GPs interviewed,
they tried to match treatment to individual
patients and the perceived cause of their insom-
nia. If a mental health issue, such as depres-
sion, was suspected, then an antidepressant
and/or a referral to the CMHT was offered.
Some CMHT practitioners suggested that they
only accepted patients with comorbid insomnia
linked to depression or anxiety of sufficient
severity which encouraged some GPs were to
cite mental health issues rather than insomnia
on referral letters, in order for their patient to
access CMHT services. This sometimes led to
patient and CMHT confusion about the reason
for referral where GPs sent referral letters stat-
ing a diagnosis of depression or anxiety when
the patient thought that their referral was for
insomnia.
Despite patients agreeing that their insomnia
may have been connected to physical, psycho-
logical, social or a combination of these, their
main concern was lack of sleep. The following
quotation reflects many patients’ views about
the frustration they felt when their insomnia
was not prioritized:
I would like them [clinicians] to say, right let’s
look into it. But I know there is such a wide
number of reasons why people don’t sleep that it
would be too expensive, to look into everybody
that doesn’t sleep, but it isn’t taken seriously, it
is a health problem I think and it isn’t taken seri-
ously enough. (Pt. Int. 03)
A few patients also expressed confusion
about why a GP would prescribe drugs for
depression when they were presenting with a
sleep problem:
I don’t want to be on anti-depressants for a sleep
problem. (Pt. Int. 11)
It was clear from the way some GPs and
some community mental health professionals
talked about insomnia that they believed; in
the case of potential mental health issues, it
was these that were the cause of insomnia as
the following quotation shows:
If there’s a realisation that there is a mental
health issue, for that patient, they should see
somebody far more expert in that field as soon
as possible because for some people their medical
condition is having a major impact upon their
sleep pattern. (CP Prof. Int. 12)
Most professionals described how they first
explored lifestyle issues contributing to insom-
nia, gave advice and provided a sleep hygiene
leaflet. Some GPs said that while they dis-
cussed sleep hygiene with patients, they did not
believe that many of their patients would even
attempt to try it.
Most of them already have a mindset, as soon as
you start talking about sleep hygiene being the
way to go, they switch off. That may be a preju-
dice of mine but that’s my observation. (GP
Prof. Int. 04)
Although GPs offering sleep hygiene felt that
patients ‘switched-off’ to this advice, many
pharmacists, in contrast expressed that patients
seeking help for insomnia at a pharmacy were
often satisfied, at least on their first visit, to
receive lifestyle advice about their sleep pat-
terns, rather than purchase an over-the-counter
remedy. This suggested that patients tried vari-
ous strategies to combat their sleep problems
prior to the next step of seeking medication
from their GP. This was evident in a number
of patients’ recollections, when they said that
they knew all about sleep hygiene. In some
cases, if sleep hygiene strategies were suggested
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by a health professional, patients perceived this
to be a too simplistic and even a dismissive
intervention for the severity of their insomnia.
Yes I’ve been through all that. I don’t have a
television in the bedroom. I don’t have anything
like that in the bedroom. I’ve been through all
the sleep hygiene stuff side of it, I do all that
yeah. (Pt. Int. 03)
Rarely, if ever, was referral or access to
CBT-I offered as a treatment for primary or
comorbid insomnia by either GPs or CMHT
members indicating that this was seldom used
for insomnia treatment in the regions.
Although GPs knew about CBT, they were less
familiar or convinced with it as a potential
treatment for insomnia. As one GP stated:
I can’t remember having specifically referred
patients to a specific CBT website. I know I have
given people lists of various mental health web-
sites which includes modules on CBT (GP Prof.
Int. 03).
Moreover, GPs suggested that, before they
would consider using CBT-I, they would have
to see positive evidence of benefit to patients,
implying that they had little or no personal
experience of patients using or benefitting from
CBT-I. Many pharmacists and all the patients
were also unaware of the utility of CBT-I.
There was a complex array of psychological,
social and physical scenarios GPs had to con-
tend with in relation to insomnia sufferers fol-
lowing the initial assessment, attempts at sleep
hygiene strategies and patient demands for
hypnotics (see below). The tension between
prescribing hypnotics, which most GPs sug-
gested they did not want to do long-term, was
due to their perception of potential harms and
widespread recommendations of short-term
treatment. This was complicated by the GP–
patient interaction, where feelings were engen-
dered in the GP by patients’ stories of distress.
Prescribing and drug taking
General practitioners stated that they would
prescribe a one-off, short course of hypnotics
when patients asked for these, particularly in
situations of bereavement or where sleep
hygiene had not worked, to avoid confronta-
tion. They also suggested that they did so reluc-
tantly, warning patients that it was a short-term
solution which would not be repeated.
Some people do come in and ask if they can have
a sleeping tablet. The wrong thing to do is just
to say ‘no’. You automatically get into this con-
frontational situation. So I usually say ‘yes that’s
okay, but let’s talk about what’s been going on’,
and then we can go through everything else […]
If they do insist on that, then I would do what
[name of another GP in practice] does, a very
short course of benzodiazepine type medication.
(GP Prof. FG. 17)
Despite some doctors wishing to prescribe
hypnotics only short-term, others conceded that
they often behaved differently in practice, when
faced with a patient who had severe insomnia.
They felt empathetic towards their patient who
was undergoing life stresses and colluded in pre-
scribing hypnotics by arguing that the benefits
outweighed potential disadvantages.
I think you know there will be doctors who say I
never prescribe hypnotics because it’s wrong.
Why is it wrong? Well it’s just wrong. The
answer is in my view, the correct view, is that we
are here to help patients and if somebody has to
have a benzodiazepine occasionally to make their
lives tolerable then that’s not a bad price to pay
and if that helps them to get through life and to
survive their job, their marriage or their financial
crisis then so be it. You’ve got to be humane
about these things, not be an intellectual purist
[…] I think you will never ever avoid prescribing
something like that, because if you won’t
prescribe it, then people will turn to alcohol or
turn to illicit substances to use instead. (GP Prof.
FG. 22)
This GP felt hypnotics were a short-term crisis
intervention and a humane practice that would
benefit patients with insomnia.
According to many of the GPs interviewed,
patients often requested hypnotics and repeat-
edly returned to the surgery for more. Interest-
ingly, GPs said that they tried to dissuade
patients, who they thought were only ‘drug
seeking’, from short-term hypnotics. However,
the pharmacists we interviewed also suggested
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that long-term repeat prescribing was more
common and they observed GPs hypnotic pre-
scribing practices which contrasted with their
stated short-term approach, a conclusion which
they derived from the prescriptions being pre-
sented and medicine review meetings with GPs.
It is perfectly normal for a 28-day prescription of
zopiclone from day one and I think the patient’s
perception is that once they’ve got the prescrip-
tion they can then take one tablet every night.
(CP Prof. FG. 13)
Pharmacists observed that acute prescriptions
often led to long-term prescribing of hypnotics.
We do sadly have the scenario where it [sleep
medication] was prescribed when they’ve lost a
loved one, maybe a year ago and it was on
repeat then and they still carry on taking it, and
that sadly is still, in my experience, quite com-
mon […] I work with a very good group of doc-
tors who are very patient conscious, yet, it still
happens. (CP Prof. FG. 19)
Some patients, particularly those who had
suffered with insomnia for many years, wanted
to manage their own insomnia and wanted
hypnotics repeatedly prescribed. They felt best
placed to self-medicate and described how they
had learned to actualize their goal of accessing
medication.
I went to see one of the lady doctors who’s no
longer there and all she gave me was a load of
bumph about insomnia which y’know I knew
what it was and what happens, but she didn’t give
me the tablets that time, so I went back to see the
doctor I am actually registered with and he was a
lot more helpful, he always is. (Pt. Int. 10)
From these data, we can see that prescribing
was longer-term and more widespread than just
short-term and contextual as some GPs sug-
gested. Our data suggest that GPs and by
default patients considered two main treatment
options, sleep hygiene and hypnotic drugs, per-
haps because of the general acceptance of these
as viable care for insomnia.
Some patients developed creative, but unli-
censed, ways to stockpile hypnotic drugs or
enhance their effects. For example, to tailor a
bespoke regimen for themselves they said that
they were splitting the medication and taking
half a tablet when they woke at night, taking
drugs on alternate nights or mixing them with
over-the-counter remedies.
I’m on zopiclone from the GP […] I use it as
and when […] I use only half a tablet. There are
times when I use it every night for a couple of
weeks, then other times where I take Kalms
night-time, Nytol. I’ve tried Phenergan, just
because nothing works for long. (Pt. Int. 03)
One patient suggested:
Following my bereavement […] I found that tak-
ing one tablet wasn’t enough. I had to take at
least two […] two was fine for a short while, but
then that became not enough so I had to take
three, to even get relaxed […] When I explained
this to the doctor he wouldn’t prescribe me any
more, because that was an addictive way of tak-
ing them. (Pt. Int. 15)
Sometimes doctors took a hard line, when
potentially dangerous use of hypnotics was
reported and refused to prescribe further drugs.
This required patients to ‘play the system’ to
obtain prescriptions. GPs rarely considered
that patients might modify their drug regimen.
There was little evidence of support involving
patients and GPs discussing the safety issues or
appropriate doses of hypnotics use if they were
being used in such ad hoc ways. Disclosures of
these kinds by patients to GPs were not com-
mon, which may have contributed to GPs’
inability to understand exactly how patients
were using prescribed hypnotics and their
sometimes unfounded assumption that patients
would take hypnotics as prescribed.
Addiction* and withdrawal
Contrary to those patients who were sporad-
ically self-medicating, a number of other
patients were concerned about long-term use
*We have retained the concept ‘addiction’ to represent the
data expressed by patients, GPs and pharmacists in this
study. While the clinical definition of ‘addiction’ seems to
suggest a compulsive dependence on a behaviour or sub-
stance, we understand that ‘dependency’ is the term that
may better reflect contemporary understandings of patients’
use of hypnotics.
ª 2013 John Wiley & Sons Ltd Health Expectations
Experiences of primary care for insomnia, Z Davy, J Middlemass and A N Siriwardena 7
and addiction to hypnotics. This was evident in
accounts offered by patients and some pharma-
cists. For instance, a community pharmacist
said:
“Will I be addicted to these” I think is the most
common question [from patients]. I think there’s
a lot of medication [hypnotics] collected that isn’t
taken, that sits on shelves. (CP Prof. FG. 13)
General practitioners often discussed the addic-
tive potential of hypnotic drugs with patients
but varied in their attitude and response to
potential dependence; some were much less
concerned about addiction, particularly in rela-
tion to different patient groups, for example
older patients.
Yes, I suppose quite often [I prescribe hypnotics],
but not to everybody. I just warn them that it
can be addictive to take it […] often with older
people or where there is a risk of addiction, it’s
not going to be the end of the world if they do
get addicted to them. (GP Prof. Int. 03)
Patients, GPs, pharmacists and CMHT fre-
quently stated the need to discontinue long-
term hypnotics but withdrawal was sometimes
ad hoc or unplanned.
If one of their [patients’] goals is to be able to
come off medication they need to be motivated
to actually put that in place, because there’s no
point doing one or two days then having a tablet
and then non the next day. So that’s where it
would depend on their motivation, if they want
to change it. But for some, if GPs, if they are
just going to carry on prescribing, they [patients]
are getting a good night’s sleep, so they’re going
to carry on taking the medication. (CMHT Prof.
Int. 09).
Mental health practitioners and GPs differed
in the way they thought withdrawal of hypnot-
ics should be organized.
So with a few people who maybe have tried
sleeping tablets for a while, I’ll try stopping them
for a while or just having them periodically. (GP
Prof. Int. 03)
However, patients felt withdrawal from
hypnotics needed to be handled sensitively with
alternative support offered for insomnia, rather
than simply withdrawing drugs.
The last time I went [to the GP], he said to me,
‘you know we are not supposed to prescribe
these anymore’ and he had a training doctor with
him actually. I said ‘yes but I’ve got so many
problems’. I said ‘there’s nothing you can do?’
and he said ‘no’. […] His comments were, ‘you
should be trying to do without them’, without
any other kind of help. (Pt. Int. 05)
Nonetheless, some patients described how
GPs just stopped hypnotic medication without
their insomnia being treated; this was based on
length of time that drugs had been taken, rather
than whether the insomnia had improved.
Just to be told you should come off the zopiclone
is not what you want to hear […] It is a health
problem I think, and it isn’t taken seriously
enough […] I do think there ought to be more
things available through the GP. (Pt. Int. 03)
Practitioners sometimes explored patients’
readiness to stop hypnotics and discussed the
importance of gradual withdrawal.
‘Once I’m on it I can’t come off’, is quite a com-
mon concept and its talking it through with them
[patients] and saying, ‘Well actually, yes you can,
we’re not going to stop immediately and we’re
going to work down’. (CP Prof. FG. 13)
Withdrawal interventions were not widely used
and reasons behind the reluctance of practitio-
ners to implement gradual withdrawal in con-
junction with a patient’s readiness to reduce
long-term hypnotic therapy was often not clear.
However, fear of addiction to hypnotics, which
for some patients had become a reality, was also
evident. GPs and pharmacists were also con-
cerned about patients’ long-term use. Worry-
ingly, GPs in this study were sometimes
reported to stop prescribing hypnotics abruptly
rather than tailing these off, because of con-
cerns about addiction. While CMHT profes-
sionals suggested that patient motivation
coupled with complete withdrawal from medi-
cation use was a better option for patients.
More options, better education and training
Many practitioners perceived a lack of options
for patients presenting with insomnia and
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welcomed more training and a wider range of
treatment options.
I have got a patient that we just can’t do any-
thing, there’s nowhere else or nothing else I can
offer and he’s still got insomnia problems […] I
don’t know where else to go from there, when
things don’t work. (N Prof. Int. 18)
Patients, particularly those who were dissat-
isfied with drug treatment for sleep problems,
also agreed that GPs would benefit from edu-
cation in managing insomnia.
Anything that can help a GP and educate them
[about insomnia] rather than giving out antide-
pressants has got to be good. (Pt. Int. 11)
Because what you don’t get when you go and see
a GP, in my opinion, is very good advice because
they haven’t had proper training […] so they’re
not up to speed, and they’ve got 10 minutes to
talk to you if you’re lucky. (Pt. FG. 18)
Practitioners who had attended specific
insomnia training felt that they had benefitted:
Well I went to have a one day course on insom-
nia […] there was a lot of useful information […]
so that when a patient comes in, I can identify
the severity of the insomnia, a bit of background
around it, some general discussion and then they
[patients] go away with some ideas and back-
ground reading of what the condition entails. (N
Prof. Int. 18)
Patients and all the health practitioners con-
cur that more options should be available for
treatment and that health professionals should
have better training in treating insomnia.
Discussion
We have shown that health professionals’
approach to insomnia primarily focused on
assessment and treatment of comorbidities, par-
ticularly social problems, anxiety, depression
and physical disorders, as established in other
studies.17,18 Similarly, patients, while under-
standing the importance of their insomnia being
connected to physical, psychological, social
problems or a combination of these, felt that
these often took precedence in clinical consulta-
tions. This detracted from the treatment for
insomnia itself,17,19 which if provided could
lead to improvements in symptoms and quality
of life, even in comorbid insomnia.20 The ten-
sion here is the position of insomnia in GPs’
perception in which insomnia is treated as an
effect of underlying psychosocial or physical ill-
health manifestations rather than it contribut-
ing to them. There is some evidence in this
study that GPs more readily recommended psy-
chological treatments for anxiety and depres-
sion, whereas hypnotics were often prescribed
early for insomnia,21,22 despite CBT-I being rec-
ommended first-line.8,23 GPs or CMHT rarely
considered CBT-I as a viable option for insom-
nia itself and patients rarely asked about this as
a treatment option.
Although practitioners described a stepped-
care approach, care provided was often inade-
quate because it did not involve the most effec-
tive psychological treatment, CBT-I, either self-
administered or delivered in primary care.24
Instead they focused on sleep hygiene advice
which, although a prerequisite for other ele-
ments of CBT-I, has little evidence of effective-
ness by itself.25,26 Sleep hygiene advice was not
always well received or used by patients,
because they were sceptical about its effective-
ness, a finding which is evident in other stud-
ies.19 Indeed, older people with sleep
complaints often report little difference in sleep
hygiene practices, other than daytime napping,
than those without sleep complaints.27
It is well established that GPs prescribe
hypnotics for a variety of reasons: patients ask
directly for sleeping tablets when they are
distressed and GPs feel under pressure to pre-
scribe to avoid confrontation,11,19,28 or to
maintain a good doctor–patient relationship.29
Many feel that drugs work, particularly for
acute situations.12,30 Drugs are also prescribed
in the face ‘of insolvable psychosocial prob-
lems’31 to show empathy10 or to prevent alco-
hol or drug abuse.29 Sometimes drugs are used
because another doctor began prescribing
them,31 or to meet actual and perceived patient
expectations or to save time.32
Our data support the diverse contextual
influences on hypnotic prescribing but we
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have also shown that patients sometimes want
to self-medicate and continue to receive pre-
scriptions as and when they need them. This
leads patients, especially long-term users of
hypnotics, to strategically negotiate prescrip-
tions to support their self-medication prac-
tices. We found little evidence, except in a few
cases, where GPs and patients used a concor-
dance approach to hypnotic drug regimens
involving honest information sharing about
their use. According to Weiss and Britten,
this would balance the doctor–patient relation-
ship, enabling GPs to help patients deter-
mine appropriate drug doses until they are
ready to try alternative treatments or cease
taking medication.33 After all, as Pound
et al.34, pp. 50 suggest, the doctor ‘maybe in
control during the consultation but [is] oddly
powerless once the person has left the surgery’
with a prescription.
A small minority of practitioners in our
study, who prescribed long-term hypnotics,
saw their prescribing habits as being appropri-
ate and defensible, which has also been found
in other studies.10,30,31 Fear of addiction to
hypnotics was common among patients and
practitioners in our study, but for a minority
of doctors, addiction was not perceived to be a
problem for some groups, such as the elderly
or terminally ill. Some previous studies have
highlighted that patients are concerned about
addiction and try to stop hypnotics, often with-
out success,9,35 whereas others show that
patients and their physicians are often reluctant
to discontinue these drugs.36,37 Patients did
express concerns about hypnotics, centred on
addiction and side-effects, to community phar-
macists in our study, but there was little com-
munication of this to GPs.
Limited communication and professional
barriers between pharmacists, GPs and com-
munity mental health practitioners can often
lead to lack of coordination of care and
absence of a much needed interprofessional
approach to the problem of insomnia.38 Studies
have shown a reluctance of behalf of pharma-
cists to get more involved in hypnotics due to
concerns about undermining patient confidence
and a fear of inappropriately challenging pre-
scribers.39
Other studies have highlighted limited time
and poor access to mental health services to be
barriers to effective management of insom-
nia.10,13 Although programmes such as
Improving Access to Psychological Therapies39
now provide better access to non-pharmacolog-
ical therapies for conditions, such as anxiety
and depression, CBT-I is still not widely used
or available, mainly because of the lack of
trained providers.40,41 We add to this by show-
ing that CBT-I is rarely considered by health
professionals and patients as a stand-alone
option for insomnia, due to lack of awareness
about the evidence and poor knowledge of the
technique.
Strengths and limitations
The strengths of this study were as follows: the
wide range of perspectives gleaned from
patients and health professionals; the triangula-
tion of different views; divergent case analysis;
and rigorous analysis and interpretation of
data. This was a multidisciplinary study involv-
ing academics from general practice; nursing
and social science. We recruited from two large
counties in one area of the UK. Although this
may not completely reflect experiences else-
where and we acknowledge that qualitative
studies are not generalizable to the entire
population in the traditional sense, we are con-
fident that our methods generated conceptual
generalizability.42
Implications for further research or clinical
practice
The failure to treat insomnia effectively may be
explained, at least in part, by lack of under-
graduate or postgraduate clinical education
and training. A previous study of UK medical
education found that practitioners received an
average of five minutes training on insomnia
during undergraduate medical education.43
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Better education and training for manage-
ment of sleep problems is needed and should
incorporate better understanding of the clini-
cians’ role, more accurate sleep assessment and
training in CBT-I.19 Improved training for
health professionals in managing insomnia, a
recognized primary care pathway for insomnia
including GP, pharmacists, and CMHT, as well
as increased public awareness of non-pharma-
cological approaches to treatment for insomnia
is needed. Further research looking at the
role and communication between community
pharmacists and prescribers of hypnotics is
warranted.
Conclusion
This study has elicited GPs’, CHMTs’, phar-
macists’ and patients’ beliefs about the treat-
ment for insomnia. There were important
differences between perceptions of treatment.
Current treatment for insomnia is contextual
and influenced by practitioners’ and patients’
perceived understanding about underlying psy-
chosocial, physical and psychological causes of
insomnia. It was clear that the patients wanted
to have their insomnia treated, while practitio-
ners understood that the underlying causes
needed exploring. Nonetheless, hypnotics were
prescribed, sometimes long-term, creating a sit-
uation where patients’ often self-managed their
hypnotic intake as and when needed. CBT-I
was rarely offered or requested as a solution to
insomnia. There is evidence for the efficacy of
CBT-I23; therefore, there needs to be consis-
tently better management of insomnia in
primary care, including use of non-pharmaco-
logical approaches for patients presenting with
insomnia for the first time as well as those on
long-term hypnotics. This would be helped by
improving training for health professionals car-
ing for patients with insomnia.
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